New Orleans, LA

Best Clinical Trials, LLC

Rhinosinusitis

Nasal Polyps

Chronic Obstructive Pulmonary Disease

Lung Diseases

Polyps

Sinusitis

Obstructive Lung Diseases

BHV-3000

Astegolimab

Pfizer

Roche

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COPD) who are former or current smokers and have a history of frequent exacerbations.

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

Best Clinical Trials, LLC | New Orleans, LA

Site insights

Work at this site?

Active trials

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (ARNASA)

Trial sponsors